Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-02-27 @ 5:10 PM
Study NCT ID:
NCT00418535
Status:
COMPLETED
Last Update Posted:
2009-10-21
First Post:
2007-01-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma
Sponsor:
Samsung Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2004-10-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
CISL (Consortium to Improve Lymphoma Survival)
Old Organization:
CISL (Consortium to Improve Lymphoma Survival)